Binnopharm Group is the leader in planning submissions to bring registration dossiers into compliance with the EAEU requirements

Binnopharm Group was recognized as the winner in the nomination «Leaders in planning submissions to bring registration dossiers into compliance with the requirements of the Eurasian Economic Union» at the scientific and practical conference «Regulatory Practice and Registration of Medicines 2023».


Gulnara Setdekova, Director of Research and Regulatory Affairs, Binnopharm Group: «The development of the broad market of medicines within the Eurasian Economic Union leads to the formation of new regulatory requirements for conducting trials, formation and submission of registration dossiers on the platform of the EAEU regulatory framework. Now there is a transition period, and it is especially important to organize work properly and effectively organize within the company to bring registration dossiers in line with the requirements. Binnopharm Group is the leader in this respect. The strategy we have developed to bring registration dossiers into compliance with the requirements of the EAEU allows us to complete successfully the necessary procedures in the shortest possible time». 


244 marketing authorizations makes 94.94% of Binnopharm Group's active portfolio of pharmaceuticals have already been brought into compliance with the requirements of international treaties and acts constituting the law of the Eurasian Economic Union.